ReHydration
- Manufacturer
- Energetix Corp
- Effective date
- 2022-11-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:18:35
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients 59.1 mL contains 4% of Adenosinum cyclophosphoricum 12X, 30X; Coffea cruda 9X; Glandula suprarenalis suis
9X, 12X, 6C; Hypothalamus 12X, 6C, 12C; Kali phos 6X, 12X, 30X; Nat mur 8X, 12X, 30X; Sarsaparilla 4X, 6X, 12X, 6C; Silicea 12X, 30X; Taraxacum 4X; Thyroidinum 12X, 6C, 12C.
Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
INDICATIONS & USAGE SECTION
Uses
Temporary relief of increased or decreased thirst, dryness, headaches.
WARNINGS SECTION
Warnings
- In case of overdose, get medical help or contact a Poison Control Center right away.
- If pregnant or breast-feeding, ask a healthcare professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- Keep out of reach of children.
DOSAGE & ADMINISTRATION SECTION
Directions
- MUST BE ADDED TO LIQUID.
- Add 15 drops per liter of water or as directed by a healthcare professional.
- Consult a physician for use in children under 12 years of age or if symptoms worsen or persist.
OTHER SAFETY INFORMATION
Other information
- Store at room temperature out of direct sunlight.
- Do not use if neck wrap is broken or missing.
- Shake well before use.
INACTIVE INGREDIENT SECTION
Inactive ingredients
Ethyl Alcohol, Glycerin, Purified Water.
OTC - QUESTIONS SECTION
Questions? Comments?
800.990.7085
www.goenergetix.com
Distributed by Energetix Corp.
Dahlonega, GA 30533
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
energetix
ReHydration
Homeopathic Remedy
Increased or decreased thirst, dryness, headaches.
2 fl oz (59.1 mL) / 15% Ethyl Alcohol
OTC - PURPOSE SECTION
Purpose
Temporary relief of increased or decreased thirst, dryness, headaches.
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64578-0173-1 | ReHydration | 59.1 mL in 1 BOTTLE | LIQUID | 59.1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64578-0173 | REHYDRATION (ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS, KALI PHOS, NAT MUR, SARSAPARILLA, SILICEA, TARAXACUM, THYROIDINUM) LIQUID [ENERGETIX CORP] | 3 | Legacy NDC, 1 package rows | 20221118_fbc8e22b-37d1-48aa-870e-7d2087eaaeaf.zip |
Products#
Every source-derived product name is available through these pages.
- ReHydration
- Adenosinum cyclophosphoricum, Coffea cruda, Glandula suprarenalis suis, Hypothalamus, Kali phos, Nat mur, Sarsaparilla, Silicea, Taraxacum, Thyroidinum
- ADENOSINE CYCLIC PHOSPHATE
- ARABICA COFFEE BEAN
- SUS SCROFA ADRENAL GLAND
- BOS TAURUS HYPOTHALAMUS
- DIBASIC POTASSIUM PHOSPHATE
- PHOSPHATE ION
- SODIUM CHLORIDE
- CHLORIDE ION
- SMILAX ORNATA ROOT
- SARSAPARILLA
- TARAXACUM OFFICINALE
- THYROID, UNSPECIFIED
- ALCOHOL
- GLYCERIN
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64578-0173 | 64578-0173-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ADENOSINE CYCLIC PHOSPHATE | E0399OZS9N | ACTIB |
| ARABICA COFFEE BEAN | 3SW678MX72 | ACTIB |
| SUS SCROFA ADRENAL GLAND | 398IYQ16YV | ACTIB |
| BOS TAURUS HYPOTHALAMUS | S6G2NLH4Y7 | ACTIB |
| DIBASIC POTASSIUM PHOSPHATE | CI71S98N1Z | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| SMILAX ORNATA ROOT | 2H1576D5WG | ACTIB |
| TARAXACUM OFFICINALE | 39981FM375 | ACTIB |
| THYROID, UNSPECIFIED | 0B4FDL9I6P | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 75b6d721-57c3-45c4-aff8-dac529bc8428 | fbc8e22b-37d1-48aa-870e-7d2087eaaeaf | 2022-11-17 | Warnings | 75b6d721-57c3-45c4-aff8-dac529bc8428 fbc8e22b-37d1-48aa-870e-7d2087eaaeaf |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
